Clinical Response Predictive Model for Omalizumab in Moderate-to-Severe Asthma Patients

Figure 4

Nomogram predictive model for clinical response of omalizumab to moderate-to-severe asthma. Values for each variable are individually plotted and correspond to point values assigned from the point scale (top). These point values are then totaled and plotted on the total point scale (bottom), which is used to assign a corresponding value for prediction. (AE: protocol-defined exacerbations during the past year; FEV1%FVC: FEV1 percentage of forced vital capacity; 4wIgE: bIgE: the week 4: baseline IgE ratio).